Different viral vectors have been analyzed as gene delivery vehicles t
o skeletal muscle for potentially therapeutic purposes. In this review
, we evaluate the application of retroviral, adenoviral, and herpes si
mplex viral vectors to deliver genes to skeletal muscle and focus on t
he dramatic loss of viral transduction detected throughout muscle matu
ration. Recent results suggested that there are several factors involv
ed in the reduced viral transducibility of mature skeletal muscle: mus
cle cells become post-mitotic in an early stage, the extracellular mat
rix develops into a physical barrier, and a loss of myoblast mediation
occurs since myoblasts progressively become quiescent. Approaches to
improve viral gene delivery to mature skeletal muscle may include the
use of particular enzymes to increase the permeability of the extracel
lular matrix, the pre-treatment of the muscle with a myonecrotic agent
to induce myoblast mediation, or the application of the myoblast-medi
ated ex vivo gene transfer. (C) 1998 Elsevier Science B.V.